THE EFFECT OF THE RTS,S/AS01E VACCINE FOURTH DOSE ON CELL MEDIATED IMMUNE RESPONSES TO CSP AND HBSAG ANTIGENS IN AFRICAN CHILDREN

被引：0

作者：

Jairoce, Chenjerai ^{[1
]}

Mitchell, Robert A. ^{[2
]}

Aguilar, Ruth ^{[2
]}

Naidu, Akshayata ^{[2
]}

Chopo, Ana ^{[2
]}

Mpina, Maxmillian ^{[3
]}

McCall, Matthew B. B. ^{[4
]}

Vazquez-Santiago, Miquel ^{[2
]}

Ruiz-Olalla, Gemma ^{[2
]}

Diez-Padrisa, Nuria ^{[2
]}

Williams, Nana A. ^{[2
]}

Campo, Joseph J. ^{[2
]}

Aide, Pedro ^{[1
]}

Mordmueller, Benjamin ^{[4
]}

Agnandji, Selidji T. ^{[5
]}

Daubenberger, Claudia ^{[6
]}

Moncunill, Gemma ^{[2
]}

Dobano, Carlota ^{[2
]}

机构：

[1] CISM, Maputo, Mozambique

[2] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain

[3] Bagamoyo Res & Training Ctr, Ifakara Hlth Inst, Bagamoyo, Tanzania

[4] Univ Tubingen, German Ctr Infect Res, Inst Trop Med, Tubingen, Germany

[5] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Ghana

[6] Swiss Trop & Publ Hlth Inst, Basel, Switzerland

来源：

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2019年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

429

引用

页码：131 / 131

页数：1

共 49 条

[41] Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial
Dicko, Alassane
Ouedraogo, Jean-Bosco
Zongo, Issaka
Sagara, Issaka
Cairns, Matthew
Yerbanga, Rakiswende Serge
Issiaka, Djibrilla
Zoungrana, Charles
Sidibe, Youssoufa
Tapily, Amadou
Nikiema, Frederic
Sompougdou, Frederic
Sanogo, Koualy
Kaya, Mahamadou
Yalcouye, Hama
Dicko, Oumar Mohamed
Diarra, Modibo
Diarra, Kalifa
Thera, Ismaila
Haro, Alassane
Sienou, Abdoul Aziz
Traore, Seydou
Mahamar, Almahamoudou
Dolo, Amagana
Kuepfer, Irene
Snell, Paul
Grant, Jane
Webster, Jayne
Milligan, Paul
Lee, Cynthia
Ockenhouse, Christian
Ofori-Anyinam, Opokua
Tinto, Halidou
Djimde, Abdoulaye
Chandramohan, Daniel
Greenwood, Brian
LANCET INFECTIOUS DISEASES, 2024, 24 (01): : 75 - 86
[42] Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial
Valea, Innocent
Adjei, Samuel
Usuf, Effua
Traore, Ousmane
Ansong, Daniel
Tinto, Halidou
Boateng, Harry Owusu
Leach, Amanda
Some, Athanase Mwinessobaonfou
Buabeng, Patrick
Vekemans, Johan
Nana, Louis Arnaud
Kotey, Amos
Vandoolaeghe, Pascale
Ouedraogo, Florence
Sambian, David
Lievens, Marc
Tahita, Marc Christian
Rettig, Theresa
Jongert, Erik
Lompo, Palpouguini
Idriss, Ali
Borys, Dorota
Ouedraogo, Sayouba
Prempeh, Frank
Habib, Md Ahsan
Schuerman, Lode
Sorgho, Hermann
Agbenyega, Tsiri
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (06) : 1489 - 1500
[43] Antigen-Specific IL-2 Secretion Correlates with NK Cell Responses after Immunization of Tanzanian Children with the RTS,S/AS01 Malaria Vaccine
Horowitz, Amir
Hafalla, Julius C. R.
King, Elizabeth
Lusingu, John
Dekker, Denise
Leach, Amanda
Moris, Philippe
Cohen, Joe
Vekemans, Johan
Villafana, Tonya
Corran, Patrick H.
Bejon, Philip
Drakeley, Chris J.
von Seidlein, Lorenz
Riley, Eleanor M.
JOURNAL OF IMMUNOLOGY, 2012, 188 (10): : 5054 - 5062
[44] Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults
Giacomet, Vania
Masetti, Michela
Nannini, Pilar
Forlanini, Federica
Clerici, Mario
Zuccotti, Gian Vincenzo
Trabattoni, Daria
PLOS ONE, 2018, 13 (02):
[45] The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial (vol 25, pg 335, 2025)
Macia, D.
Campo, J. J.
Jairoce, C.
LANCET INFECTIOUS DISEASES, 2025, 25 (03): : E137 - E137
[46] Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial (vol 11, pg 102, 2011)
Olotu, A.
Lusingu, J.
Leach, A.
LANCET INFECTIOUS DISEASES, 2011, 11 (03): : 159 - 159
[47] Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial
Juraska, Michal
Early, Angela M.
Li, Li
Schaffner, Stephen F.
Lievens, Marc
Khorgade, Akanksha
Simpkins, Brian
Hejazi, Nima S.
Benkeser, David
Wang, Qi
Mercer, Laina
Adjei, Samuel
Agbenyega, Tsiri
Anderson, Scott
Ansong, Daniel
Bii, Dennis K.
Buabeng, Patrick B. Y.
English, Sean
Fitzgerald, Nicholas
Grimsby, Jonna
Kariuki, Simon K.
Otieno, Kephas
Roman, Francois
Samuels, Aaron M.
Westercamp, Nelli
Ockenhouse, Christian F.
Ofori-Anyinam, Opokua
Lee, Cynthia K.
Macinnis, Bronwyn L.
Wirth, Dyann F.
Gilbert, Peter B.
Neafsey, Daniel E.
LANCET INFECTIOUS DISEASES, 2024, 24 (09): : 1025 - 1036
[48] Efficacy of RTS,S/AS01 E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial (vol 22, pg 1329, 2022)
Samuels, A. M.
Ansong, D.
Kariuki, S. K.
LANCET INFECTIOUS DISEASES, 2022, 22 (11): : E310 - E310
[49] CELL-MEDIATED AND HUMORAL IMMUNE RESPONSES AFTER VACCINATION WITH A 3-ANTIGEN HBV VACCINE CONTAINING PRE-S1, PRE-S2, AND S ANTIGENS, COMPARED TO A SINGLE-ANTIGEN HBV VACCINE: RESULTS FROM A PIVOTAL PHASE-3 RANDOMIZED CLINICAL TRIAL (PROTECT)
Diaz-Mitoma, Francisco
Vesikari, Timo
Langley, Joanne
Leroux-Roels, Isabel
Leroux-Roels, Geert
Clement, Frederic
Waerlop, Gwenn
Machluf, Nathalie
Yang, Lanjian
Berthoud, Tamara
Ahmed, Tanvir
Soares, Catalina
Spaans, Johanna
Yassin-Rajkumar, Bebi
Anderson, David E.
Popovic, Vladimir
HEPATOLOGY, 2021, 74 : 430A - 430A

← 1 2 3 4 5 →